A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

Stopped Janssen made the strategic decision to discontinue the DAISY study. This decision is not based on any safety concerns.

Conditions

• Respiratory Tract Infections

Interventions

• DRUG: Rilematovir
• DRUG: Rilematovir X mg/kg
• DRUG: Placebo

Sponsor

Janssen Research & Development, LLC